Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

Share Price is delayed by 15 minutes
Get Live Data
2,178.00    -4.00 (-0.18%)
Bid:
2,192.00
Ask:
2,220.00
Spread: 28.00 (1.277%)
Market Cap: £1.45b
GNS Live PriceLast checked at - London Stock Exchange

Intraday Genus Share Chart

Director/PDMR Shareholding

17 Sep 2018 17:27

RNS Number : 0305B
Genus PLC
17 September 2018
 

17 September 2018

 

Genus plc

 

Director/PDMR Shareholding

 

Genus plc (LSE: GNS) announces that, further to the vesting of conditional nil-cost options on 14 September 2018 under the Genus 2014 Performance Share Plan (the 'PSP') and the Genus Deferred Share Bonus Plan (the 'DSBP') as listed in table A and table B below respectively, a member of the Genus Executive Leadership Team ('GELT') sold ordinary shares in Genus on 14 September 2018 on the London Stock Exchange, with income tax and social security liabilities due on the PSP exercise being deducted from the sale proceeds and the balance of funds retained, and income tax and social security liabilities due on the DSBP exercise being offset by ordinary shares sold and the balance of ordinary shares retained.

 

In addition, further to the vesting of conditional shares on 14 September 2018 under the Genus 2014 Performance Share Plan (the 'PSP') as listed in table C below, a member of the Genus Executive Leadership Team ('GELT') sold ordinary shares in Genus on 14 September 2018 on the London Stock Exchange, with income tax and social security liabilities due on the release being deducted from the sale proceeds and the balance of funds retained.

 

The below notifications, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail of the number of nil-cost options exercised and ordinary shares sold on 14 September 2018 and also the number of conditional shares released and ordinary shares sold on 14 September 2018.

 

For further information please contact:

 

Genus:

Josie Havita, Interim Deputy Company Secretary Tel: +44 (0)1256 347100

 

 

Table A - GELT 2014 Performance Share Plan Exercise

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Jonathan Lightner

2.

Reason for the notification

a.

Position/status

Chief Scientific Officer & Head of Genus R&D

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Exercise of 14,375 nil-cost options under the PSP.

 

c.

Price(s) and volume(s)

Price(s)

 

0p

Volume(s)

 

14,375

 

d.

Aggregated information

· Aggregated volume

· Price

Average Price(s)

 

0p

Volume(s)

 

14,375

 

 

e.

Date of the transaction

2018-09-14

f.

Place of the transaction

Outside a trading venue.

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

 

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

GB0002074580

b.

Nature of the transaction

Sale of 14,375 shares arising from the exercise of nil-cost options under the PSP.

c.

Price(s) and volume(s)

Price(s)

 

2,506p

Volume(s)

 

14,375

 

d.

Aggregated information

· Aggregated volume

· Price

Average Price(s)

 

2,506p

Volume(s)

 

14,375

 

 

e.

Date of the transaction

2018-09-14

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

Table B - GELT Deferred Share Bonus Plan Exercise 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Jonathan Lightner

2.

Reason for the notification

a.

Position/status

Chief Scientific Officer & Head of Genus R&D

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Exercise of 3,850 nil-cost options under the DSBP.

 

c.

Price(s) and volume(s)

Price(s)

 

0p

Volume(s)

 

3,850

 

d.

Aggregated information

· Aggregated volume

· Price

Average Price(s)

 

0p

Volume(s)

 

3,850

 

 

e.

Date of the transaction

2018-09-14

f.

Place of the transaction

Outside a trading venue.

 

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

b.

Nature of the transaction

Sale of 1,301 shares arising from the exercise of nil-cost options under the DSBP to offset income tax and social security liabilities due on the exercise.

c.

c.

Price(s) and volume(s)

Price(s)

 

2,505.5266p

Volume(s)

 

1,301

 

d.

d.

Aggregated information

· Aggregated volume

· Price

Price(s)

 

2,505.5266p

Volume(s)

 

1,301

 

e.

Date of the transaction

2018-09-14

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

Table C - GELT 2014 Performance Share Plan Release

5.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Angelle Rosata

6.

Reason for the notification

a.

Position/status

Group Human Resources Director

 

b.

Initial notification

/Amendment

Initial notification

7.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

8.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.

Nature of the transaction

Release of 1,499 conditional shares under the PSP.

 

c.

Price(s) and volume(s)

Average price(s)

 

0p

Total volume(s)

 

1,499

 

d.

Aggregated information

· Aggregated volume

· Price

 

Average price(s)

 

0p

Total volume(s)

 

1,499

 

e.

Date of the transaction

2018-09-14

f.

Place of the transaction

Outside a trading venue.

 

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

e.

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

f.

b.

Nature of the transaction

Sale of 1,499 shares arising from the release of conditional shares under the PSP.

 

g.

c.

Price(s) and volume(s)

Price(s)

 

2,500.0p

Total volume(s)

 

1,499

 

h.

d.

Aggregated information

· Aggregated volume

· Price

 

Average price(s)

 

2,500.0p

 

Total volume(s)

 

1,499

e.

Date of the transaction

2018-09-14

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUBUNRWVAKAAR
Date   Source Headline
13th May 202612:32 pmRNSDirector/PDMR Shareholding
1st May 20269:20 amRNSTotal Voting Rights
13th Apr 20265:59 pmRNSDirector/PDMR Shareholding
1st Apr 20269:40 amRNSDirector/PDMR Shareholding
10th Mar 20263:56 pmRNSNotification of Major Holdings
10th Mar 20263:56 pmRNSNotification of Major Holdings
4th Mar 202610:33 amRNSDirector/PDMR Shareholding
4th Mar 202610:08 amRNSDirector Declaration
27th Feb 202612:48 pmRNSDirector/PDMR Shareholding
26th Feb 20267:00 amRNSInterim Results
2nd Feb 202612:39 pmRNSBlock Listing Return
2nd Feb 202611:21 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSSuccessful formation of Chinese porcine JV
23rd Jan 20265:23 pmRNSPRP Regulatory Progress – Canada
16th Jan 20267:00 amRNSHalf Year Trading Update – Ahead of expectations
27th Nov 20257:00 amRNSDirector/PDMR Shareholding
19th Nov 202512:12 pmRNSResults of AGM
19th Nov 20257:00 amRNSNon-Executive Director Appointments
19th Nov 20257:00 amRNSAGM Trading Update
3rd Nov 202510:56 amRNSTotal Voting Rights
14th Oct 20254:02 pmRNSNotification of Major Holdings
10th Oct 20257:00 amRNSNotice of AGM
1st Oct 20259:47 amRNSTotal Voting Rights
25th Sep 20254:49 pmRNSDirector/PDMR Shareholding
24th Sep 202511:35 amRNSDirector/PDMR Shareholding
19th Sep 20252:39 pmRNSDirector/PDMR Shareholding
17th Sep 202512:14 pmRNSDirector/PDMR Shareholding
11th Sep 202512:20 pmRNSDirector/PDMR Shareholding
8th Sep 20254:05 pmRNSAdditional Listing
4th Sep 20257:00 amRNSPreliminary results
4th Sep 20257:00 amRNSAccelerated Chinese porcine JV formation
28th Aug 20254:57 pmRNSNotification of Major Holdings
19th Aug 20253:03 pmRNSNotification of Major Holdings
19th Aug 20257:00 amRNSNotification of Major Holdings
6th Aug 202510:51 amBUSHolding(s) in Company
4th Aug 202511:14 amRNSNotification of Major Holdings
1st Aug 202510:10 amRNSBlock Listing Six Monthly Return
1st Aug 202510:05 amRNSTotal Voting Rights
15th Jul 20257:00 amRNSFY25 Trading Update
9th May 20259:25 amRNSAppointment of Financial Adviser & joint Broker
1st May 20252:28 pmRNSTotal Voting Rights
30th Apr 20257:00 amRNSPRRS Resistant Pig – FDA Approval
25th Apr 20254:30 pmRNSNotification of Major Holdings
25th Apr 20254:28 pmRNSNotification of Major Holdings
2nd Apr 20255:08 pmRNSDirector/PDMR Shareholding
2nd Apr 20253:43 pmRNSNotification of Major Holdings
13th Mar 20257:00 amRNSAppointment of Chief Financial Officer Designate
3rd Mar 202511:32 amRNSTotal Voting Rights
28th Feb 20251:30 pmRNSDirector/PDMR Shareholding
27th Feb 20257:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.